{"id":"W4311625660","doi":"10.3390/curroncol29120744","title":"A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pemetrexed; Medicine; Bosutinib; Oncology; Internal medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Progressive disease; Chemotherapy; Pharmacology; Dasatinib; Cisplatin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001348211,0.00150872,0.001971181,0.0004759333,0.0004639722,0.0006989524,0.0007157691,0.0008902899,0.001684162],"category_scores_gemma":[0.0008172246,0.0006310723,0.001330895,0.0003819826,0.0007620056,0.0006226716,0.0002955798,0.002890268,0.0004533332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008511502,"about_ca_system_score_gemma":0.001160989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008288078,"about_ca_topic_score_gemma":0.001986514,"domain_scores_codex":[0.9996388,0.000167325,0.00001738679,0.00005591625,0.00003617141,0.00008429835],"domain_scores_gemma":[0.9994503,0.00009303345,0.0001044787,0.00003901575,0.00003895091,0.0002742891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4857801,0.1866309,0.01740542,0.001303581,0.002305239,0.001338106,0.001016857,0.005440661,0.1345145,0.0005568214,0.005647998,0.1580598],"study_design_scores_gemma":[0.3483092,0.6219279,0.01665035,0.00003223083,0.0003941886,0.0005487041,0.00008692596,0.001947852,0.007479418,0.0001760581,0.002419917,0.00002717535],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956891,0.001017511,0.0003863782,0.0003352521,0.00006824188,0.001227466,0.0003130537,0.00003730836,0.0009255377],"genre_scores_gemma":[0.9938489,0.001127749,0.001272676,0.0004189582,0.0001252175,0.001148943,0.0008643288,0.00001269248,0.001180585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001971181,"threshold_uncertainty_score":0.007130086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02968397435600007,"score_gpt":0.3897604351764058,"score_spread":0.3600764608204057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}